NovoCure Ltd. (NVCR)
14.99
-0.21
(-1.38%)
USD |
NASDAQ |
Oct 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
NovoCure Enterprise Value : 1.553B for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.553B |
| October 02, 2026 | 1.523B |
| October 01, 2026 | 1.637B |
| September 30, 2026 | 1.640B |
| September 29, 2026 | 1.645B |
| September 28, 2026 | 1.626B |
| September 25, 2026 | 1.627B |
| September 24, 2026 | 1.669B |
| September 23, 2026 | 1.675B |
| September 22, 2026 | 1.724B |
| September 21, 2026 | 1.708B |
| September 18, 2026 | 1.726B |
| September 17, 2026 | 1.730B |
| September 16, 2026 | 1.672B |
| September 15, 2026 | 1.663B |
| September 14, 2026 | 1.672B |
| September 11, 2026 | 1.589B |
| September 10, 2026 | 1.570B |
| September 09, 2026 | 1.603B |
| September 08, 2026 | 1.745B |
| September 04, 2026 | 1.872B |
| September 03, 2026 | 1.837B |
| September 02, 2026 | 1.859B |
| September 01, 2026 | 1.807B |
| August 31, 2026 | 1.838B |
| Date | Value |
|---|---|
| August 28, 2026 | 1.858B |
| August 27, 2026 | 1.878B |
| August 26, 2026 | 1.866B |
| August 25, 2026 | 1.835B |
| August 24, 2026 | 1.735B |
| August 21, 2026 | 1.774B |
| August 20, 2026 | 1.852B |
| August 19, 2026 | 1.902B |
| August 18, 2026 | 1.790B |
| August 17, 2026 | 1.824B |
| August 14, 2026 | 1.757B |
| August 13, 2026 | 1.807B |
| August 12, 2026 | 1.831B |
| August 11, 2026 | 1.839B |
| August 10, 2026 | 1.799B |
| August 07, 2026 | 1.691B |
| August 06, 2026 | 1.610B |
| August 05, 2026 | 1.652B |
| August 04, 2026 | 1.677B |
| August 03, 2026 | 1.567B |
| July 31, 2026 | 1.511B |
| July 30, 2026 | 1.556B |
| July 29, 2026 | 1.553B |
| July 28, 2026 | 1.682B |
| July 27, 2026 | 1.766B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Smith & Nephew plc | 13.04B |
| LivaNova Plc | 4.043B |
| Tristel Plc | -- |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.66M |
| Revenue (Quarterly) | 183.58M |
| Total Expenses (Quarterly) | 199.24M |
| EPS Diluted (Quarterly) | -0.135 |
| Gross Profit Margin (Quarterly) | 77.61% |
| Profit Margin (Quarterly) | -8.53% |
| Earnings Yield | -8.74% |
| Normalized Earnings Yield | -8.736 |